The Scientist

» drug development, ecology and culture

Most Recent

image: Cannabis-Based Drug for Epilepsy

Cannabis-Based Drug for Epilepsy

By | March 14, 2016

A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 

0 Comments

image: Student Fights Harassment with Wikipedia

Student Fights Harassment with Wikipedia

By | March 10, 2016

Every time Emily Temple-Wood receives an inappropriate email, she writes a Wikipedia entry about a woman scientist.

8 Comments

A study suggests bats in Asia could have genes that protect them from the fungal infection that is decimating bat populations in North America.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2016

Herding Hemingway's Cats, Hair: A Human History, Restless Creatures, and The Mind Club

0 Comments

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

image: In Your Dreams

In Your Dreams

By | March 1, 2016

Understanding the sleeping brain may be the key to unlocking the secrets of the human mind.

1 Comment

image: Speaking of Science

Speaking of Science

By | March 1, 2016

March 2016's selection of notable quotes

1 Comment

image: Things That Go Bump

Things That Go Bump

By | March 1, 2016

Scientists still don’t know why animals sleep or how to define the ubiquitous behavior.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

1 Comment

image: Keep Off the Grass

Keep Off the Grass

By | February 1, 2016

Ecologists focused on grasslands urge policymakers to keep forestation efforts in check.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech